Clinical Indications for Treatment with Multi-Kinase Inhibitors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer

SIMPLE SUMMARY: Differentiated thyroid cancer generally has an indolent, slow-growing nature. The disease gradually progresses in some of the patients and can ultimately develop into life-threatening conditions. Multi-kinase inhibitors including sorafenib and lenvatinib demonstrated prolonged progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Naoki, Takahashi, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126102/
https://www.ncbi.nlm.nih.gov/pubmed/34068664
http://dx.doi.org/10.3390/cancers13092279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126102/
https://www.ncbi.nlm.nih.gov/pubmed/34068664
http://dx.doi.org/10.3390/cancers13092279

Ejemplares similares